Companies/US/SMMT

SUMMIT THERAPEUTICS INC.

Last · NasdaqGM$15.37+0.24 (+1.59%)live · yahoo · 43m ago
Vol 4.72M ≈ 72.58M
Market cap$12.26B797.7M sh
P/E · TTM-14.2fwd -13.2 · eps -1.08 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$12.07$29.23
Volume4.7Msession

Issuer

Legal nameSUMMIT THERAPEUTICS INC.
HQUnited States (US)
ListingUS SMMT
ISINUS86627T1088
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001599298
CIK0001599298
Employees265
AddressSummit Therapeutics, Inc. 601 Brickell Key Drive 33131, Miami
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-02-23

From latest 10-K · 2026-02-23

  • Operating Cf Burn
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.7 years
  • Accumulated Deficit High — Accumulated deficit / equity 348%

Upcoming earnings

1 event
10:00 PM UTC+2
Period
Sep 2026
Est. EPS
−$0.21
Est. revenue
54,000

Documents

FormReporting forFiledFlags
2026-10-082026-10-140